Trial · NCT05419583
Registered outcomes16
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 16 of 16
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Trial process outcomes: eligibility, approach, consent and randomisation | 90 days | The proportion of patients who are eligible, approached, consented and randomised |
| Secondary | Recruitment rate | 30 days and 90 days | Rate per month and overall |
| Secondary | Adherence to recommended investigation | 90 days | Determined as the proportion of patients who received recommended investigation |
| Secondary | Adherence to recommended treatment | 90 days | Determined as the proportion of patients who received recommended treatment |
| Secondary | Proportion of patients with changes in prescription of secondary prevention therapy | 90 days | Defined as initiation, intensification or cessation of cardiac medication including aspirin, clopidogrel, statin, bisoprolol or ACE-inhibitor and others as defined in data dictionary. |
| Secondary | Frequency of investigation and treatment | 90 days | Proportion of patients who undergo routine cardiac investigation (echocardiography, invasive coronary angiography, percutaneous coronary intervention, CT coronary angiography, cardiac MRI) in the standard care arm per month |
| Secondary | Change in classification of myocardial infarction | 90 days | Proportion of patients in whom the classification of myocardial infarction changes after study intervention |
| Secondary | Quantity of missing data | Baseline and 90 days | |
| Other | Rate of myocardial infarction | 90 days | As per the Fourth Universal Definition |
| Other | Rate of all-cause death | 90 days | |
| Other | Rate of cardiovascular death | 90 days | Defined as death resulting from an acute myocardial infarction, sudden cardiac death, death due to heart failure, death due to stroke, death due to haemorrhage, and death due to other cardiovascular causes |
| Other | Rate of cardiac death | 90 days | Defined as death resulting from an acute myocardial infarction, sudden cardiac death, or death due to heart failure. |
| Other | Rate of non-cardiovascular death | 90 days | Defined as death arising from any other cause not listed under cardiovascular death |
| Other | Rate of hospitalisation with heart failure | 90 days | |
| Other | Rate of unscheduled coronary revascularization | 90 days | |
| Other | Rate of major bleeding | 90 days | Bleeding Academic Research Consortium \[BARC\] 3-5 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05419583/registered